annual CAPEX:
$232.97M-$85.56M(-26.86%)Summary
- As of today (May 30, 2025), CRL annual capital expenditures is $232.97 million, with the most recent change of -$85.56 million (-26.86%) on December 28, 2024.
- During the last 3 years, CRL annual CAPEX has risen by +$4.20 million (+1.83%).
- CRL annual CAPEX is now -28.26% below its all-time high of $324.73 million, reached on December 31, 2022.
Performance
CRL CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CAPEX:
$59.32M-$16.29M(-21.55%)Summary
- As of today (May 30, 2025), CRL quarterly capital expenditures is $59.32 million, with the most recent change of -$16.29 million (-21.55%) on March 29, 2025.
- Over the past year, CRL quarterly CAPEX has dropped by -$19.82 million (-25.04%).
- CRL quarterly CAPEX is now -44.49% below its all-time high of $106.88 million, reached on March 1, 2023.
Performance
CRL quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CAPEX:
$213.15M-$19.82M(-8.51%)Summary
- As of today (May 30, 2025), CRL TTM capital expenditures is $213.15 million, with the most recent change of -$19.82 million (-8.51%) on March 29, 2025.
- Over the past year, CRL TTM CAPEX has dropped by -$77.65 million (-26.70%).
- CRL TTM CAPEX is now -39.30% below its all-time high of $351.14 million, reached on March 1, 2023.
Performance
CRL TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
CRL CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -26.9% | -25.0% | -26.7% |
| 3 y3 years | +1.8% | -26.3% | -24.2% |
| 5 y5 years | +65.8% | +130.6% | +42.6% |
CRL CAPEX Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -28.3% | +1.8% | -44.5% | +53.2% | -39.3% | at low |
| 5 y | 5-year | -28.3% | +65.8% | -44.5% | +130.6% | -39.3% | +49.5% |
| alltime | all time | -28.3% | +1856.2% | -44.5% | +2349.4% | -39.3% | +7550.6% |
CRL CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $59.32M(-21.5%) | $213.15M(-8.5%) |
| Dec 2024 | $232.97M(-26.9%) | $75.62M(+95.3%) | $232.97M(-1.1%) |
| Sep 2024 | - | $38.72M(-1.9%) | $235.67M(-10.4%) |
| Jun 2024 | - | $39.49M(-50.1%) | $262.90M(-9.6%) |
| Mar 2024 | - | $79.14M(+1.0%) | $290.80M(-8.7%) |
| Dec 2023 | $318.53M(-1.9%) | $78.32M(+18.8%) | $318.53M(-3.3%) |
| Sep 2023 | - | $65.95M(-2.1%) | $329.23M(-1.9%) |
| Jun 2023 | - | $67.38M(-37.0%) | $335.68M(-4.4%) |
| Mar 2023 | - | $106.88M(+20.1%) | $351.14M(+8.1%) |
| Dec 2022 | $324.73M(+41.9%) | $89.02M(+23.0%) | $324.73M(-2.9%) |
| Sep 2022 | - | $72.39M(-12.6%) | $334.48M(+5.3%) |
| Jun 2022 | - | $82.85M(+3.0%) | $317.63M(+13.0%) |
| Mar 2022 | - | $80.46M(-18.5%) | $281.21M(+22.9%) |
| Dec 2021 | $228.77M(+37.4%) | $98.78M(+77.9%) | $228.77M(+5.0%) |
| Sep 2021 | - | $55.54M(+19.6%) | $217.85M(+15.6%) |
| Jun 2021 | - | $46.43M(+65.6%) | $188.50M(+11.6%) |
| Mar 2021 | - | $28.03M(-68.1%) | $168.87M(+1.4%) |
| Dec 2020 | $166.56M(+18.5%) | $87.85M(+235.5%) | $166.56M(+16.8%) |
| Sep 2020 | - | $26.18M(-2.3%) | $142.54M(-5.9%) |
| Jun 2020 | - | $26.80M(+4.2%) | $151.52M(+1.4%) |
| Mar 2020 | - | $25.72M(-59.7%) | $149.50M(+6.4%) |
| Dec 2019 | $140.51M(+0.3%) | $63.84M(+81.6%) | $140.51M(-3.3%) |
| Sep 2019 | - | $35.16M(+41.9%) | $145.35M(+9.6%) |
| Jun 2019 | - | $24.78M(+48.1%) | $132.63M(+2.8%) |
| Mar 2019 | - | $16.73M(-75.6%) | $129.06M(-7.9%) |
| Dec 2018 | $140.05M(+69.9%) | $68.68M(+206.1%) | $140.05M(+40.2%) |
| Sep 2018 | - | $22.44M(+5.8%) | $99.88M(+0.4%) |
| Jun 2018 | - | $21.21M(-23.5%) | $99.45M(+5.5%) |
| Mar 2018 | - | $27.73M(-2.7%) | $94.24M(+14.3%) |
| Dec 2017 | $82.43M(+49.1%) | $28.50M(+29.5%) | $82.43M(+3.5%) |
| Sep 2017 | - | $22.01M(+37.6%) | $79.61M(+18.5%) |
| Jun 2017 | - | $16.00M(+0.5%) | $67.16M(+6.7%) |
| Mar 2017 | - | $15.92M(-38.0%) | $62.96M(+13.9%) |
| Dec 2016 | $55.29M(-12.6%) | $25.68M(+168.4%) | $55.29M(-4.4%) |
| Sep 2016 | - | $9.57M(-18.9%) | $57.85M(-1.5%) |
| Jun 2016 | - | $11.79M(+42.9%) | $58.74M(-3.5%) |
| Mar 2016 | - | $8.25M(-70.8%) | $60.85M(-3.8%) |
| Dec 2015 | $63.25M(+11.1%) | $28.24M(+170.2%) | $63.25M(+2.0%) |
| Sep 2015 | - | $10.45M(-24.8%) | $62.03M(+1.7%) |
| Jun 2015 | - | $13.91M(+30.6%) | $60.98M(+8.1%) |
| Mar 2015 | - | $10.65M(-60.6%) | $56.38M(-1.0%) |
| Dec 2014 | $56.92M(+45.4%) | $27.02M(+187.4%) | $56.92M(+30.1%) |
| Sep 2014 | - | $9.40M(+0.9%) | $43.74M(+0.7%) |
| Jun 2014 | - | $9.31M(-16.8%) | $43.44M(-1.1%) |
| Mar 2014 | - | $11.19M(-19.1%) | $43.91M(+12.2%) |
| Dec 2013 | $39.15M(-17.6%) | $13.84M(+52.1%) | $39.15M(+0.2%) |
| Sep 2013 | - | $9.10M(-7.1%) | $39.06M(-2.9%) |
| Jun 2013 | - | $9.79M(+52.3%) | $40.20M(+0.9%) |
| Mar 2013 | - | $6.43M(-53.2%) | $39.85M(-16.2%) |
| Dec 2012 | $47.53M | $13.74M(+34.1%) | $47.53M(-22.4%) |
| Sep 2012 | - | $10.24M(+8.5%) | $61.27M(+3.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2012 | - | $9.44M(-33.1%) | $59.25M(+4.9%) |
| Mar 2012 | - | $14.11M(-48.6%) | $56.47M(+14.9%) |
| Dec 2011 | $49.14M(+14.7%) | $27.47M(+234.1%) | $49.14M(+30.4%) |
| Sep 2011 | - | $8.22M(+23.4%) | $37.68M(-2.3%) |
| Jun 2011 | - | $6.66M(-1.9%) | $38.59M(-4.4%) |
| Mar 2011 | - | $6.79M(-57.6%) | $40.36M(-5.8%) |
| Dec 2010 | $42.86M(-46.3%) | $16.01M(+75.4%) | $42.86M(-0.7%) |
| Sep 2010 | - | $9.13M(+8.3%) | $43.18M(-17.8%) |
| Jun 2010 | - | $8.43M(-9.3%) | $52.52M(-18.6%) |
| Mar 2010 | - | $9.29M(-43.1%) | $64.52M(-19.2%) |
| Dec 2009 | $79.85M(-59.5%) | $16.33M(-11.6%) | $79.85M(-26.3%) |
| Sep 2009 | - | $18.46M(-9.6%) | $108.38M(-20.6%) |
| Jun 2009 | - | $20.44M(-17.0%) | $136.56M(-24.6%) |
| Mar 2009 | - | $24.63M(-45.1%) | $181.08M(-8.1%) |
| Dec 2008 | $197.08M(-13.2%) | $44.85M(-3.8%) | $197.08M(-18.4%) |
| Sep 2008 | - | $46.64M(-28.2%) | $241.59M(-1.5%) |
| Jun 2008 | - | $64.95M(+59.9%) | $245.28M(+6.8%) |
| Mar 2008 | - | $40.63M(-54.5%) | $229.74M(+1.2%) |
| Dec 2007 | $227.04M(+24.9%) | $89.36M(+77.5%) | $227.04M(+3.4%) |
| Sep 2007 | - | $50.34M(+1.9%) | $219.66M(+3.5%) |
| Jun 2007 | - | $49.41M(+30.3%) | $212.29M(+17.8%) |
| Mar 2007 | - | $37.92M(-53.7%) | $180.28M(-0.8%) |
| Dec 2006 | $181.75M(+92.3%) | $81.99M(+90.8%) | $181.75M(+46.2%) |
| Sep 2006 | - | $42.97M(+146.9%) | $124.33M(-2.5%) |
| Jun 2006 | - | $17.40M(-55.8%) | $127.55M(+5.0%) |
| Mar 2006 | - | $39.39M(+60.3%) | $121.51M(+28.6%) |
| Dec 2005 | $94.52M(+111.3%) | $24.57M(-46.8%) | $94.52M(+2.1%) |
| Sep 2005 | - | $46.19M(+306.6%) | $92.58M(+63.5%) |
| Jun 2005 | - | $11.36M(-8.4%) | $56.63M(+7.6%) |
| Mar 2005 | - | $12.40M(-45.2%) | $52.61M(+17.6%) |
| Dec 2004 | $44.73M(+36.8%) | $22.62M(+120.9%) | $44.73M(+27.6%) |
| Sep 2004 | - | $10.24M(+39.5%) | $35.05M(+16.4%) |
| Jun 2004 | - | $7.34M(+62.3%) | $30.12M(-5.9%) |
| Mar 2004 | - | $4.53M(-65.0%) | $31.99M(-2.2%) |
| Dec 2003 | $32.70M(-12.9%) | $12.94M(+143.4%) | $32.70M(-8.4%) |
| Sep 2003 | - | $5.32M(-42.3%) | $35.70M(-5.3%) |
| Jun 2003 | - | $9.22M(+76.1%) | $37.69M(-1.4%) |
| Mar 2003 | - | $5.24M(-67.1%) | $38.24M(+1.9%) |
| Dec 2002 | $37.54M(+2.4%) | $15.93M(+118.0%) | $37.54M(-0.5%) |
| Sep 2002 | - | $7.31M(-25.2%) | $37.74M(-3.8%) |
| Jun 2002 | - | $9.77M(+115.5%) | $39.24M(+6.2%) |
| Mar 2002 | - | $4.54M(-71.9%) | $36.94M(+0.8%) |
| Dec 2001 | $36.66M(+135.5%) | $16.13M(+83.2%) | $36.66M(+33.0%) |
| Sep 2001 | - | $8.80M(+17.8%) | $27.57M(+30.1%) |
| Jun 2001 | - | $7.47M(+75.7%) | $21.18M(+24.4%) |
| Mar 2001 | - | $4.25M(-39.6%) | $17.03M(+9.4%) |
| Dec 2000 | $15.56M(+20.2%) | $7.04M(+190.5%) | $15.56M(+82.5%) |
| Sep 2000 | - | $2.42M(-27.1%) | $8.53M(+39.7%) |
| Jun 2000 | - | $3.32M(+19.2%) | $6.11M(+119.2%) |
| Mar 2000 | - | $2.79M | $2.79M |
| Dec 1999 | $12.95M(+8.7%) | - | - |
| Dec 1998 | $11.91M | - | - |
FAQ
- What is Charles River Laboratories International annual capital expenditures?
- What is the all time high annual CAPEX for Charles River Laboratories International?
- What is Charles River Laboratories International annual CAPEX year-on-year change?
- What is Charles River Laboratories International quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Charles River Laboratories International?
- What is Charles River Laboratories International quarterly CAPEX year-on-year change?
- What is Charles River Laboratories International TTM capital expenditures?
- What is the all time high TTM CAPEX for Charles River Laboratories International?
- What is Charles River Laboratories International TTM CAPEX year-on-year change?
What is Charles River Laboratories International annual capital expenditures?
The current annual CAPEX of CRL is $232.97M
What is the all time high annual CAPEX for Charles River Laboratories International?
Charles River Laboratories International all-time high annual capital expenditures is $324.73M
What is Charles River Laboratories International annual CAPEX year-on-year change?
Over the past year, CRL annual capital expenditures has changed by -$85.56M (-26.86%)
What is Charles River Laboratories International quarterly capital expenditures?
The current quarterly CAPEX of CRL is $59.32M
What is the all time high quarterly CAPEX for Charles River Laboratories International?
Charles River Laboratories International all-time high quarterly capital expenditures is $106.88M
What is Charles River Laboratories International quarterly CAPEX year-on-year change?
Over the past year, CRL quarterly capital expenditures has changed by -$19.82M (-25.04%)
What is Charles River Laboratories International TTM capital expenditures?
The current TTM CAPEX of CRL is $213.15M
What is the all time high TTM CAPEX for Charles River Laboratories International?
Charles River Laboratories International all-time high TTM capital expenditures is $351.14M
What is Charles River Laboratories International TTM CAPEX year-on-year change?
Over the past year, CRL TTM capital expenditures has changed by -$77.65M (-26.70%)